Back to Search Start Over

P040 Compassionate use triple therapy CFTR modulation (Kaftrio®) in severe disease. Single-centre, real-world clinical outcomes, safety and tolerability

P040 Compassionate use triple therapy CFTR modulation (Kaftrio®) in severe disease. Single-centre, real-world clinical outcomes, safety and tolerability

Authors :
M. McCarthy
C. Howlett
D. Morrissy
S. Twohig
Desmond M. Murphy
Barry J. Plant
Tamara Vagg
C. Fleming
Yvonne McCarthy
J. Dorgan
Source :
Journal of Cystic Fibrosis. 20:S50-S51
Publication Year :
2021
Publisher :
Elsevier BV, 2021.

Abstract

Objective: Patients (F508del/F508del or F508del/MF) with severe CF (ppFEV1

Details

ISSN :
15691993
Volume :
20
Database :
OpenAIRE
Journal :
Journal of Cystic Fibrosis
Accession number :
edsair.doi...........08b8a35386fbdf600c2871d111ed0648
Full Text :
https://doi.org/10.1016/s1569-1993(21)01067-5